TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Sriram Sathy
Vice President Biology and Translational Medicine at Codiak Biosciences

Profile

Sriram Sathy is the Vice President, Biology and Translational Science at Codiak Biosciences and a distinguished scientist with more than 14 years of industry experience building, developing managing differentiated Oncology and Immuno-Oncology scientific and translational strategies. At Codiak he is responsible for building the pre-clinical pipeline. Prior to joining Codiak Sriram was Senior Director of Translational Science at Jounce, where he was responsible for building their translational science platform. Here he developed and implemented an integrated translational discovery strategy that develop patient enrichment biomarkers and indication selection and new target identification which helped transform Jounce to a publicly-traded research and development organization. Before joining Jounce, Sriram spent 6 years at Merck & Co, leading the translational oncology strategy for their multi-oncology programs that established clinical Proof of Concept (POC) for a novel combination therapy.

Sriram Sathy's Network

Agenda Sessions

  • Developing an Engineered Exosome Therapeutics Platform

    , 17:00